DHI
48
3
MCO
73
2
CRM
47
2
RIG
41
4
WRK
73
8
SHW
59
13
ALLE
48
7
AES
64
6
GOOGL
72
5
SRCL
34
3
RRC
65
3
PGR
72
-2
C
46
2
HBI
25
4
UPS
48
2
NOC
43
-5
PSA
35
-8
HSY
53
2
QCOM
80
9
SIG
72
2
DHI
48
3
MCO
73
2
CRM
47
2
RIG
41
4
WRK
73
8
SHW
59
13
ALLE
48
7
AES
64
6
GOOGL
72
5
SRCL
34
3
RRC
65
3
PGR
72
-2
C
46
2
HBI
25
4
UPS
48
2
NOC
43
-5
PSA
35
-8
HSY
53
2
QCOM
80
9
SIG
72
2
Financhill
Back

Sangamo Therapeutics 10K Form

Sell
29

SGMO
Sangamo Therapeutics

Last Price:
0.55
Seasonality Move:
-2.28%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive SGMO News And Ratings

See the #1 stock for the next 7 days that we like better than SGMO

SGMO Financial Statistics

Sales & Book Value

Annual Sales: $176.23M
Cash Flow: $-53.21M
Price / Cash Flow: 0
Annual Sales: $0.47
Price / Book: 1.13

Profitability

EPS (TTM): -1.47000
Net Income (TTM): $-257.83M
Gross Margin: $0
Return on Equity: -119.14%
Return on Assets: -75.25%

Sangamo Therapeutics Earnings Forecast

Key Sangamo Therapeutics Financial Ratios

  • The Gross Profit Margin over the past 18 years for SGMO is 0.00%.
  • The Selling, General & Administrative Expenses for SGMO have been equal to 34.71% of Gross Profit Margin.
  • The Research & Development expenses have been 132.81% of Revenue.
  • The Interest Expense is 0.00% of Operating Income.
  • The Net Earning history of SGMO is -146.30% of Total Revenues.
  • Per Share Earnings over the last 28 years have been positive in 7 years.

Sangamo Therapeutics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: SGMO
CUSIP: 800677
Website: sangamo.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 1.98
Quick Ratio: 1.72

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

SGMO Technical Analysis vs Fundamental Analysis

Sell
29
Sangamo Therapeutics (SGMO) is a Sell

Is Sangamo Therapeutics a Buy or a Sell?